Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Atomera
ATOM
$214M
| $811K | ﹤0.01% |
308,464
+14,818
| +5% | +$46.2K |
|
3427
Prelude Therapeutics
PRLD
$390M
| $811K | ﹤0.01% |
391,716
+29,765
| +8% | +$138K |
|
3428
CF Bankshares
CFBK
$236M
| $808K | ﹤0.01% |
37,325
+15,658
| +72% | +$329K |
|
3429
Taboola.com
TBLA
$1.11B
| $806K | ﹤0.01% |
239,980
-66,223
| -22% | -$218K |
|
3430
Annovis Bio
ANVS
$80M
| $799K | ﹤0.01% |
99,114
+22,881
| +30% | +$214K |
|
3431
Innovative Solutions & Support
ISSC
$361M
| $794K | ﹤0.01% |
121,757
-909
| -0.7% | -$5.79K |
|
3432
Kewaunee Scientific
KEQU
$106M
| $792K | ﹤0.01% |
23,784
+1,941
| +9% | +$91.1K |
|
3433
Forafric Global
AFRI
$301M
| $791K | ﹤0.01% |
69,758
+4,361
| +7% | +$48.4K |
|
3434
Vuzix
VUZI
$224M
| $788K | ﹤0.01% |
673,462
+25,540
| +4% | +$27.9K |
|
|
CMRX
3435
DELISTED
Chimerix, Inc.
CMRX
| $787K | ﹤0.01% |
846,249
-39,575
| -4% | -$35.3K |
|
3436
Drilling Tools International
DTI
$80.1M
| $783K | ﹤0.01% |
209,808
+50,236
| +31% | +$229K |
|
|
TBNK
3437
DELISTED
Territorial Bancorp Inc.
TBNK
| $782K | ﹤0.01% |
74,905
-4,673
| -6% | -$43.9K |
|
3438
Bridger Aerospace
BAER
$74.1M
| $780K | ﹤0.01% |
351,374
+123,158
| +54% | +$363K |
|
|
BLDP
3439
Ballard Power Systems
BLDP
$790M
| $779K | ﹤0.01% |
432,805
+146,104
| +51% | +$292K |
|
3440
Hanover Bancorp
HNVR
$198M
| $779K | ﹤0.01% |
43,512
+13,803
| +46% | +$240K |
|
3441
VistaGen Therapeutics
VTGN
$12.8M
| $778K | ﹤0.01% |
258,524
-31,570
| -11% | -$108K |
|
|
AC
3442
DELISTED
Associated Capital Group
AC
| $776K | ﹤0.01% |
21,914
+4,841
| +28% | +$159K |
|
3443
Critical Metals Corp
CRML
$1.06B
| $776K | ﹤0.01% |
104,338
+4,583
| +5% | +$41.1K |
|
|
GAN
3444
DELISTED
GAN Ltd
GAN
| $774K | ﹤0.01% |
436,926
+9,260
| +2% | +$15.3K |
|
3445
Benitec Biopharma
BNTC
$468M
| $772K | ﹤0.01% |
83,987
+20,012
| +31% | +$179K |
|
3446
Saga Communications
SGA
$63.9M
| $771K | ﹤0.01% |
53,679
+2,986
| +6% | +$44.8K |
|
|
VIGL
3447
DELISTED
Vigil Neuroscience
VIGL
| $769K | ﹤0.01% |
226,083
+66,712
| +42% | +$247K |
|
3448
Denison Mines
DNN
$2.91B
| $769K | ﹤0.01% |
420,723
+34,192
| +9% | +$60.1K |
|
|
SELF
3449
Global Self Storage
SELF
$58.8M
| $768K | ﹤0.01% |
147,429
-3,297
| -2% | -$16.7K |
|
|
LNAI
3450
Lunai Bioworks
LNAI
$10.9M
| $760K | ﹤0.01% |
19,654
-1,950
| -9% | -$135K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.